A Phase 2 Multicenter Study Evaluating the Efficacy of KTE-C19 in Subjects with Relapsed/Refractory Mantle Cell Lymphoma (r/r MCL) - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 2 Multicenter Study Evaluating the Efficacy of KTE-C19 in Subjects with Relapsed/Refractory Mantle Cell Lymphoma (r/r MCL)

Type of Cancer
Lymphoma
Locations
Hackensack
Sponsor
Kite Pharma
Protocol Number
Kite Pharma KTE-C19-102
Cancer Diagnosis
To Learn More Call
201-510-0910